Abstract
Purpose
The purpose of this study is to investigate the current status of postoperative BNP measurement in the pediatric cardiac intensive care unit (PCICU).
Methods
This was a prospective multicenter observational study. Children under 15 years old who underwent pediatric cardiac surgery were included. Postoperatively, all BNP measurement was collected in PCICU. We checked whether each BNP measurement was used for the decision-making of intervention or not. We divided the BNP measurements into 4 groups: group A 0–299 pg/ml (reference), group B 300–999 pg/ml, group C 1000–1999 pg/ml, group D ≧ 2000 pg/ml. We performed logistic regression analysis to compare the intervention ratio between group A and B, C, D. We also did multiple comparison analyses to compare the intervention ratio in each group.
Results
Thirty-nine (15.8%) measurements were used as a criterion to intervene in all BNP measurements. There was no protocol for the measurement of BNP in all institutions. The number of BNP measurements in each group is as follows: group A 113 (45.9%), group B 81 (32.9%), group C 45 (18.3%), group D 7 (2.8%). The intervention ratio in each group was 6.2% (group A), 8.6% (group B), 44.4% (group C), and 71.4% (group D). The intervention ratio of group C and D were significantly higher than group A: (Odds ratio (95%CI): 12.1(4.8–33.9), p < 0.0001, 25.2(5.2–146.2), p < 0.0001). The result of multiple comparisons is similar to logistic regression analysis.
Conclusion
High BNP concentration, especially more than 1000 pg/ml, was more often intervened upon compared to that of less than 1000 pg/ml.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00540-022-03052-9/MediaObjects/540_2022_3052_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00540-022-03052-9/MediaObjects/540_2022_3052_Fig2_HTML.png)
Similar content being viewed by others
Data Availability
Please contact author for data requests.
Abbreviations
- BNP:
-
brain natriuretic peptide
- CHD:
-
congenital heart disease
- PCICU:
-
pediatric cardiac intensive care unit
- CPB:
-
cardiopulmonary bypass
- RACHS-1:
-
risk adjustment for congenital heart surgery version 1
- IQR:
-
interquartile ranges
- CI:
-
confidence interval
References
Shang C. B-type natriuretic peptide-guided therapy for perioperative medicine? Open Heart. 2014;1(1):e000105.
Fox AA, Marcantonio ER, Collard CD, Thoma M, Perry TE, Shernan SK. Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery. Anesthesiology. 2011;114(4):807–16.
Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. Am J Cardiol. 2012;109(6):866–72.
Peng EW, Spooner R, Young D, Danton MH. Acute B-type natriuretic peptide response and early postoperative right ventricular physiology following tetralogy of Fallot’s repair. Interact Cardiovasc Thorac Surg. 2012;15(3):335–9.
Chikovani O, Hsu JH, Keller R, Karl TR, Azakie A, Adatia I. B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery. J Thorac Cardiovasc Surg. 2007;134(5):1179–87.
Cantinotti M, Storti S, Lorenzoni V, Murzi B, Marotta M, Crocetti M. Response of cardiac endocrine function to surgery stress is age dependent in neonates and children with congenital heart defects: consequences in diagnostic and prognostic accuracy of brain natriuretic peptide measurement. Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14(5):508–17.
Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16(10):e202–13.
Kim JW, Gwak M, Shin WJ, Kim HJ, Yu JJ, Park PH. Preoperative factors as a predictor for early postoperative outcomes after repair of congenital transposition of the great arteries. Pediatr Cardiol. 2015;36(3):537–42.
Nahum E, Pollak U, Dagan O, Amir G, Frenkel G, Birk E. Predictive value of B-type natriuretic peptide level on the postoperative course of infants with congenital heart disease. Isr Med Assoc J. 2013;15(5):216–20.
Kanazawa T, Egi M, Toda Y, Shimizu K, Sugimoto K, Iwasaki T. Perioperative brain natriuretic peptide in pediatric cardiac surgery patients: its association with postoperative outcomes. J Cardiothorac Vasc Anesth. 2017;31(2):537–42.
Berry JG, Askovich B, Shaddy RE, Hawkins JA, Cowley CG. Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease. Pediatr Cardiol. 2008;29(1):70–5.
Hsu JH, Keller RL, Chikovani O, Cheng H, Hollander SA, Karl TR. B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J Thorac Cardiovasc Surg. 2007;134(4):939–45.
Shih CY, Sapru A, Oishi P, Azakie A, Karl TR, Harmon C. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg. 2006;131(3):632–8.
Cannesson M, Bionda C, Gostoli B, Raisky O, di Filippo S, Bompard D. Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation. Anesth Analg. 2007;104(5):1059–65 (tables of contents).
Niedner MF, Foley JL, Riffenburgh RH, Bichell DP, Peterson BM, Rodarte A. B-type natriuretic peptide: perioperative patterns in congenital heart disease. Congenit Heart Dis. 2010;5(3):243–55.
Zheng H, Cui Y, Li K, Zhang J, Qu J, Shi H. The association between the pattern of change in N-terminal-pro-B-type natriuretic peptide and short term outcomes in children undergoing surgery for congenital heart disease. Interact Cardiovasc Thorac Surg. 2021;32(4):601–6.
Brunner-La Rocca HP, Bektas S. Biomarker guided therapy in chronic heart failure. Card Fail Rev. 2015;1(2):96–101.
Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 2017;318(8):713–20.
Cantinotti M, Giovannini S, Murzi B, Clerico A. Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases. Clin Chem Lab Med. 2011;49(4):567–80.
Price JF, Thomas AK, Grenier M, Eidem BW, O’Brian Smith E, Denfield SW. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006;114(10):1063–9.
Auerbach SR, Richmond ME, Lamour JM, Blume ED, Addonizio LJ, Shaddy RE. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the pediatric carvedilol trial. Circ Heart Fail. 2010;3(5):606–11.
Amirnovin R, Keller RL, Herrera C, Hsu JH, Datar S, Karl TR. B-type natriuretic peptide levels predict outcomes in infants undergoing cardiac surgery in a lesion-dependent fashion. J Thorac Cardiovasc Surg. 2013;145(5):1279–87.
Acknowledgements
There are no additional acknowledgements
Funding
TK received funding from grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan (MEXT/JSPS KAKENHI grant number JP26861233). This study was supported by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan (MEXT/JSPSKAKENHI grant number JP26861233).
Author information
Authors and Affiliations
Contributions
TK, TI and KS: participated in the design of the study. TK, NT, KO, MY, and SF: collected data and performed the statistical analysis. TK: wrote the manuscript. NT, KO, MY, SF, TI and KS: revised and edited the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Okayama University Hospital Institutional Review Board waived the need for obtaining informed consent and approved this study and its submission for publication (No 1507–020). If you have any question, please contact the following address.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kanazawa, T., Shimizu, K., Taga, N. et al. The frequency of postoperative BNP measurement and intervention threshold of BNP concentration in pediatric cardiac intensive care unit: a prospective multicenter observational study. J Anesth 36, 367–373 (2022). https://doi.org/10.1007/s00540-022-03052-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-022-03052-9